Iain Ross

Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.

Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The private company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million.

Fisons Plc Manufactured and supplied ethical and proprietary medicines, veterinary products, laboratory and educational scientific equipment, clinical diagnostic supplies and garden products. The company was headquartered in Ipswichm the United Kingdom.

Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom.

Powerstax Ltd. designs, manufactures and sells power conversion systems. It specializes in the design and manufacture of AC-DC and DC-DC power supplies including DC-DC converters, transformer rectifiers, configurable, modular and bulk power switched mode power supplies. The firm provides value-added and custom power supply solutions for markets including defence, medical, electro-chlorination, cathodic protection, aerospace, fuel cells, oil and gas and others. The company was founded in 1992 and is headquartered in Farnborough, the United Kingdom.

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia.

Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom.

Part of Pharmaron Beijing Co., Ltd., Allergan Biologics Ltd. develops biologics products. The private company is based in Liverpool, UK. The British company was founded in 2002 by Bernard Chan. Allergan Biologics was acquired by Pharmaron Biologics (UK) Holdings Ltd. from AbbVie, Inc. on April 30, 2021 for $165.95 million.

Pharminox Ltd develops treatments for cancer therapy. The private company is based in Abingdon, UK. The British company was founded by Neil L. Brown.

Breast Cancer Haven operates as a non-profit organization. It provide the tailored package of emotional, physical and practical support, and breast cancer treatment. The company is headquartered in London, the United Kingdom.

Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden.

Tacere Therapeutics, Inc. provides treatment of infectious diseases. It develops novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company was founded by Sara M. Hall, Amit J. Kumar, John James Monahan, and Michael J. Catelani in 2006 and is headquartered in San Jose, CA.

Ark Therapeutics Ltd. engaged in manufacturing of pharmaceutical products. The company was founded on April 30, 2018 and is headquartered in London, the United Kingdom.

Biomer Technology Ltd. designs and develops biomaterial products for medical device industry. It develops medical device and therapeutic applications, and engineered polymers; designing and manufacturing industrial grade polymers, including high temperature polyurethanes HTTPU’s, for component and device manufacture. The company was founded in 2003 by Iain Gladstone Ross and is headquartered in Runcorn, the United Kingdom.

The Institute of Directors (United Kingdom) is a community of passionate UK business leaders. The non-profit company is based in Birmingham, UK, and has subsidiaries in the United Kingdom. The British company provides professional training opportunities and access to essential help and resources for its members. The CEO of the company is Stephen Martin.

Lonza Biologics Plc manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies. The company was founded in 1897 and is headquartered in Slough, the United Kingdom.

Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland.

Premier Veterinary Group Plc provides veterinary health care services. It operates through the following segments: Premier Pet Care Plan (PPCP) United Kingdom, PPCP Europe, and PPCP USA. The firm also administers a small animal wellness plan, branded pet care plan both for its own surgeries and for third party surgeries. The company was founded on October 31, 2001 and is headquartered in Bristol, the United Kingdom.

Novagen Ltd. specializes in providing lighting design software for engineers to produce standard compliant designs for street, exterior, and outdoor lighting. The private company is based in London, UK. The British company's software is quick, easy, and intuitive to use.

Reed Business Information Ltd. provides business information, data and workflow solutions. It brings brands to an audience of decision makers worldwide through its multi-platform media of branded community websites, online subscription services, web based directories and vertical search products. The company was founded on September 27, 1918 and is headquartered in Sutton, the United Kingdom.

Part of Redmile Group LLC, Redx Oncology Ltd. is a British biotech company focused on discovering and developing novel targeted medicines for the treatment of cancer and fibrotic disease. The private company is based in Macclesfield, UK, and the CEO of the company is Derek Lindsay. The company's focus is on small molecule inhibitors for fibrotic diseases, with preclinical proof of concept demonstrated in lung and kidney fibrosis models. Redx Pharma recently signed an agreement with Jazz Pharmaceuticals for the potential treatment of raf and ras mutant tumors.

Palla Pharma Ltd. manufactures and produces narcotic raw material for the international pharmaceutical industry. Its activities include narcotic raw materials, poppy seed production and distribution, active pharmaceutical ingredient and finished dosage production and distribution. The company was founded by Jarrod Ritchie in 2004 and is headquartered in Melbourne, Australia.

Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ.